Screening Instruments for Depression in Neurologic Disorders

Their Application in the Clinic and in Research

Andres M Kanner, Angela Strobel Parsons

Research output: Chapter in Book/Report/Conference proceedingChapter

1 Citation (Scopus)

Abstract

Depressive disorders (DDs) are relatively common in most major neurologic disorders, including epilepsy, stroke, dementias, Parkinson's disease, and multiple sclerosis. These DDs have a negative impact on the course and response to therapy of the neurologic disorder. Yet, DDs remain underrecognized and undertreated. The use of screening instruments can help overcome this major problem. However, caution must be exerted in the interpretation of instruments developed for primary DDs, as several somatic and cognitive symptoms that are common in primary DDs may be the expression of symptoms of the neurologic disorder or of adverse events of pharmacotherapy. Furthermore, DDs associated with some neurologic disorders may differ in their semiology. Thus, it is desirable to have depression scales validated for each neurologic disorder. Fortunately, most instruments appear to yield comparable acceptable sensitivities and specificities.

Original languageEnglish (US)
Title of host publicationDepression in Neurologic Disorders: Diagnosis and Management
PublisherWiley-Blackwell
Pages39-51
Number of pages13
ISBN (Print)9781444330588
DOIs
StatePublished - Jul 4 2012
Externally publishedYes

Fingerprint

Depressive Disorder
Nervous System Diseases
Depression
Research
Neurobehavioral Manifestations
Multiple Sclerosis
Parkinson Disease
Dementia
Epilepsy
Stroke
Drug Therapy
Sensitivity and Specificity

Keywords

  • Alzheimer's dementia
  • Beck Depression Inventory
  • Epilepsy
  • Hospital Anxiety and Depression Screening
  • Interictal dysphoric disorder
  • Major depressive disorder
  • Parkinson's disease
  • Poststroke depression
  • Stroke

ASJC Scopus subject areas

  • Neuroscience(all)

Cite this

Kanner, A. M., & Strobel Parsons, A. (2012). Screening Instruments for Depression in Neurologic Disorders: Their Application in the Clinic and in Research. In Depression in Neurologic Disorders: Diagnosis and Management (pp. 39-51). Wiley-Blackwell. https://doi.org/10.1002/9781118348093.ch4

Screening Instruments for Depression in Neurologic Disorders : Their Application in the Clinic and in Research. / Kanner, Andres M; Strobel Parsons, Angela.

Depression in Neurologic Disorders: Diagnosis and Management. Wiley-Blackwell, 2012. p. 39-51.

Research output: Chapter in Book/Report/Conference proceedingChapter

Kanner, AM & Strobel Parsons, A 2012, Screening Instruments for Depression in Neurologic Disorders: Their Application in the Clinic and in Research. in Depression in Neurologic Disorders: Diagnosis and Management. Wiley-Blackwell, pp. 39-51. https://doi.org/10.1002/9781118348093.ch4
Kanner AM, Strobel Parsons A. Screening Instruments for Depression in Neurologic Disorders: Their Application in the Clinic and in Research. In Depression in Neurologic Disorders: Diagnosis and Management. Wiley-Blackwell. 2012. p. 39-51 https://doi.org/10.1002/9781118348093.ch4
Kanner, Andres M ; Strobel Parsons, Angela. / Screening Instruments for Depression in Neurologic Disorders : Their Application in the Clinic and in Research. Depression in Neurologic Disorders: Diagnosis and Management. Wiley-Blackwell, 2012. pp. 39-51
@inbook{fee3536a0eea449dad56163f73a73719,
title = "Screening Instruments for Depression in Neurologic Disorders: Their Application in the Clinic and in Research",
abstract = "Depressive disorders (DDs) are relatively common in most major neurologic disorders, including epilepsy, stroke, dementias, Parkinson's disease, and multiple sclerosis. These DDs have a negative impact on the course and response to therapy of the neurologic disorder. Yet, DDs remain underrecognized and undertreated. The use of screening instruments can help overcome this major problem. However, caution must be exerted in the interpretation of instruments developed for primary DDs, as several somatic and cognitive symptoms that are common in primary DDs may be the expression of symptoms of the neurologic disorder or of adverse events of pharmacotherapy. Furthermore, DDs associated with some neurologic disorders may differ in their semiology. Thus, it is desirable to have depression scales validated for each neurologic disorder. Fortunately, most instruments appear to yield comparable acceptable sensitivities and specificities.",
keywords = "Alzheimer's dementia, Beck Depression Inventory, Epilepsy, Hospital Anxiety and Depression Screening, Interictal dysphoric disorder, Major depressive disorder, Parkinson's disease, Poststroke depression, Stroke",
author = "Kanner, {Andres M} and {Strobel Parsons}, Angela",
year = "2012",
month = "7",
day = "4",
doi = "10.1002/9781118348093.ch4",
language = "English (US)",
isbn = "9781444330588",
pages = "39--51",
booktitle = "Depression in Neurologic Disorders: Diagnosis and Management",
publisher = "Wiley-Blackwell",

}

TY - CHAP

T1 - Screening Instruments for Depression in Neurologic Disorders

T2 - Their Application in the Clinic and in Research

AU - Kanner, Andres M

AU - Strobel Parsons, Angela

PY - 2012/7/4

Y1 - 2012/7/4

N2 - Depressive disorders (DDs) are relatively common in most major neurologic disorders, including epilepsy, stroke, dementias, Parkinson's disease, and multiple sclerosis. These DDs have a negative impact on the course and response to therapy of the neurologic disorder. Yet, DDs remain underrecognized and undertreated. The use of screening instruments can help overcome this major problem. However, caution must be exerted in the interpretation of instruments developed for primary DDs, as several somatic and cognitive symptoms that are common in primary DDs may be the expression of symptoms of the neurologic disorder or of adverse events of pharmacotherapy. Furthermore, DDs associated with some neurologic disorders may differ in their semiology. Thus, it is desirable to have depression scales validated for each neurologic disorder. Fortunately, most instruments appear to yield comparable acceptable sensitivities and specificities.

AB - Depressive disorders (DDs) are relatively common in most major neurologic disorders, including epilepsy, stroke, dementias, Parkinson's disease, and multiple sclerosis. These DDs have a negative impact on the course and response to therapy of the neurologic disorder. Yet, DDs remain underrecognized and undertreated. The use of screening instruments can help overcome this major problem. However, caution must be exerted in the interpretation of instruments developed for primary DDs, as several somatic and cognitive symptoms that are common in primary DDs may be the expression of symptoms of the neurologic disorder or of adverse events of pharmacotherapy. Furthermore, DDs associated with some neurologic disorders may differ in their semiology. Thus, it is desirable to have depression scales validated for each neurologic disorder. Fortunately, most instruments appear to yield comparable acceptable sensitivities and specificities.

KW - Alzheimer's dementia

KW - Beck Depression Inventory

KW - Epilepsy

KW - Hospital Anxiety and Depression Screening

KW - Interictal dysphoric disorder

KW - Major depressive disorder

KW - Parkinson's disease

KW - Poststroke depression

KW - Stroke

UR - http://www.scopus.com/inward/record.url?scp=84886353140&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84886353140&partnerID=8YFLogxK

U2 - 10.1002/9781118348093.ch4

DO - 10.1002/9781118348093.ch4

M3 - Chapter

SN - 9781444330588

SP - 39

EP - 51

BT - Depression in Neurologic Disorders: Diagnosis and Management

PB - Wiley-Blackwell

ER -